hexavalent pneumococcal polysaccharide vaccine
Vaccinewithdrawn
Approved
Jul 1, 1947
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01839175)
Timeline
Indications
Approved for
Mechanism of action
- Streptococcus pneumoniaeImmunity, active
Streptococcus pneumoniae immunity, active
Approval history
- withdrawnJul 1, 1947
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hexavalent pneumococcal polysaccharide vaccine
- hexavalent vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04766086 | Phase 2 | Sep 28, 2021 | Pfizer |
| NCT01839175 | Phase 3 | Apr 1, 2013 | Sanofi-Aventis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 1 | 1 | 1 | 2021 |
| Sanofi-Aventis | For profit | 1 | 1 | 1 | 2013 |
2 organizations
Page 1 / 1